Towa Pharmaceutical Co., Ltd. (4553.T)
JPY 2597.0
(0.12%)
JPY 2597.0
(0.12%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 189.12 Billion JPY | 25.82% |
| 2022 | 150.31 Billion JPY | 89.8% |
| 2021 | 79.19 Billion JPY | 6.88% |
| 2020 | 74.09 Billion JPY | 43.42% |
| 2019 | 51.66 Billion JPY | -11.6% |
| 2018 | 58.44 Billion JPY | -2.35% |
| 2017 | 59.84 Billion JPY | 10.2% |
| 2016 | 54.3 Billion JPY | 1.51% |
| 2015 | 53.5 Billion JPY | 189.7% |
| 2014 | 18.46 Billion JPY | 11.12% |
| 2013 | 16.62 Billion JPY | 28.72% |
| 2012 | 12.91 Billion JPY | 31.73% |
| 2011 | 9.8 Billion JPY | 15.07% |
| 2010 | 8.51 Billion JPY | 111.62% |
| 2009 | 4.02 Billion JPY | 0.0% |
| 2008 | - JPY | 0.0% |
| 2007 | - JPY | 0.0% |
| 2006 | - JPY | 0.0% |
| 2005 | - JPY | 0.0% |
| 2004 | - JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 198.05 Billion JPY | 4.72% |
| 2023 Q4 | 189.12 Billion JPY | 3.0% |
| 2023 Q3 | 183.61 Billion JPY | 7.4% |
| 2023 FY | 189.12 Billion JPY | 25.82% |
| 2023 Q2 | 170.95 Billion JPY | 1.86% |
| 2023 Q1 | 167.82 Billion JPY | 11.65% |
| 2022 Q2 | 91.94 Billion JPY | 18.82% |
| 2022 Q3 | 136.54 Billion JPY | 48.51% |
| 2022 Q4 | 150.31 Billion JPY | 10.09% |
| 2022 FY | 150.31 Billion JPY | 89.8% |
| 2022 Q1 | 77.37 Billion JPY | -2.29% |
| 2021 Q2 | 66.24 Billion JPY | -8.38% |
| 2021 Q1 | 72.3 Billion JPY | -2.42% |
| 2021 FY | 79.19 Billion JPY | 6.88% |
| 2021 Q4 | 79.19 Billion JPY | 22.56% |
| 2021 Q3 | 64.61 Billion JPY | -2.46% |
| 2020 FY | 74.09 Billion JPY | 43.42% |
| 2020 Q1 | 59.43 Billion JPY | 15.03% |
| 2020 Q2 | 57.91 Billion JPY | -2.54% |
| 2020 Q3 | 56.32 Billion JPY | -2.75% |
| 2020 Q4 | 74.09 Billion JPY | 31.55% |
| 2019 FY | 51.66 Billion JPY | -11.6% |
| 2019 Q4 | 51.66 Billion JPY | -2.98% |
| 2019 Q3 | 53.25 Billion JPY | -3.46% |
| 2019 Q2 | 55.16 Billion JPY | -3.15% |
| 2019 Q1 | 56.95 Billion JPY | -2.54% |
| 2018 Q3 | 55.32 Billion JPY | -3.11% |
| 2018 Q4 | 58.44 Billion JPY | 5.64% |
| 2018 FY | 58.44 Billion JPY | -2.35% |
| 2018 Q1 | 58.45 Billion JPY | -2.33% |
| 2018 Q2 | 57.09 Billion JPY | -2.31% |
| 2017 Q1 | 53.73 Billion JPY | -1.05% |
| 2017 FY | 59.84 Billion JPY | 10.2% |
| 2017 Q4 | 59.84 Billion JPY | -2.29% |
| 2017 Q3 | 61.25 Billion JPY | -0.38% |
| 2017 Q2 | 61.48 Billion JPY | 14.42% |
| 2016 Q3 | 54.85 Billion JPY | -0.67% |
| 2016 FY | 54.3 Billion JPY | 1.51% |
| 2016 Q1 | 53.13 Billion JPY | -0.69% |
| 2016 Q4 | 54.3 Billion JPY | -0.99% |
| 2016 Q2 | 55.22 Billion JPY | 3.94% |
| 2015 Q1 | 28.31 Billion JPY | 53.3% |
| 2015 Q2 | 45.63 Billion JPY | 61.21% |
| 2015 Q3 | 45.41 Billion JPY | -0.5% |
| 2015 Q4 | 53.5 Billion JPY | 17.82% |
| 2015 FY | 53.5 Billion JPY | 189.7% |
| 2014 Q4 | 18.46 Billion JPY | -4.38% |
| 2014 Q3 | 19.31 Billion JPY | 24.84% |
| 2014 Q2 | 15.47 Billion JPY | -4.69% |
| 2014 FY | 18.46 Billion JPY | 11.12% |
| 2014 Q1 | 16.23 Billion JPY | -2.33% |
| 2013 Q2 | 12.08 Billion JPY | -8.17% |
| 2013 FY | 16.62 Billion JPY | 28.72% |
| 2013 Q3 | 16.69 Billion JPY | 38.18% |
| 2013 Q4 | 16.62 Billion JPY | -0.46% |
| 2013 Q1 | 13.15 Billion JPY | 1.91% |
| 2012 FY | 12.91 Billion JPY | 31.73% |
| 2012 Q4 | 12.91 Billion JPY | -7.41% |
| 2012 Q3 | 13.94 Billion JPY | -2.45% |
| 2012 Q2 | 14.29 Billion JPY | -6.77% |
| 2012 Q1 | 15.33 Billion JPY | 56.44% |
| 2011 FY | 9.8 Billion JPY | 15.07% |
| 2011 Q2 | 10.4 Billion JPY | -7.51% |
| 2011 Q3 | 10.55 Billion JPY | 1.44% |
| 2011 Q1 | 11.25 Billion JPY | 32.07% |
| 2011 Q4 | 9.8 Billion JPY | -7.13% |
| 2010 Q1 | 4 Billion JPY | -0.62% |
| 2010 Q4 | 8.51 Billion JPY | -2.65% |
| 2010 FY | 8.51 Billion JPY | 111.62% |
| 2010 Q2 | 9 Billion JPY | 125.0% |
| 2010 Q3 | 8.75 Billion JPY | -2.78% |
| 2009 FY | 4.02 Billion JPY | 0.0% |
| 2009 Q2 | 4 Billion JPY | 0.0% |
| 2009 Q3 | 4 Billion JPY | 0.0% |
| 2009 Q4 | 4.02 Billion JPY | 0.63% |
| 2009 Q1 | - JPY | 0.0% |
| 2008 Q4 | - JPY | 0.0% |
| 2008 FY | - JPY | 0.0% |
| 2008 Q3 | - JPY | 0.0% |
| 2007 FY | - JPY | 0.0% |
| 2006 FY | - JPY | 0.0% |
| 2005 FY | - JPY | 0.0% |
| 2004 FY | - JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.23 Billion JPY | -15263.444% |
| Takeda Pharmaceutical Company Limited | 4476.5 Billion JPY | 95.775% |
| Sumitomo Pharma Co., Ltd. | 133.36 Billion JPY | -41.807% |
| Shionogi & Co., Ltd. | 8.75 Billion JPY | -2060.676% |
| Wakamoto Pharmaceutical Co.,Ltd. | - JPY | -Infinity% |
| Nippon Shinyaku Co., Ltd. | 1.15 Billion JPY | -16317.014% |
| Kaken Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Eisai Co., Ltd. | 134.77 Billion JPY | -40.328% |
| Morishita Jintan Co., Ltd. | 106 Million JPY | -178318.868% |
| Hisamitsu Pharmaceutical Co., Inc. | 76 Million JPY | -248747.368% |
| Mochida Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Fuso Pharmaceutical Industries,Ltd. | 7.02 Billion JPY | -2593.69% |
| Nippon Chemiphar Co., Ltd. | 13.34 Billion JPY | -1317.296% |
| Tsumura & Co. | 54.37 Billion JPY | -247.801% |
| Kissei Pharmaceutical Co., Ltd. | - JPY | -Infinity% |
| Torii Pharmaceutical Co., Ltd. | 22 Million JPY | -859554.545% |
| Fuji Pharma Co., Ltd. | 11.92 Billion JPY | -1486.078% |
| Zeria Pharmaceutical Co., Ltd. | 7.94 Billion JPY | -2280.775% |
| KYORIN Holdings, Inc. | 435 Million JPY | -43376.782% |
| Taiko Pharmaceutical Co.,Ltd. | 2.74 Billion JPY | -6799.818% |
| Daito Pharmaceutical Co.,Ltd. | 4.66 Billion JPY | -3950.632% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 27 Million JPY | -700359.259% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -45748.242% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 4.5 Billion JPY | -4098.091% |
| Sawai Group Holdings Co., Ltd. | 66.84 Billion JPY | -182.946% |
| Cyfuse Biomedical K.K. | 345 Million JPY | -54718.551% |
| Toho Holdings Co., Ltd. | 28.16 Billion JPY | -571.462% |
| Koa Shoji Holdings Co.,Ltd. | 1.59 Billion JPY | -11784.247% |